Dr Christina Lynn Goodridge, MD - Medicare Obstetrics/gynecology in Hattiesburg, MS

Dr Christina Lynn Goodridge, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Hattiesburg, Mississippi. She went to Georgetown University School Of Medicine and graduated in 1996 and has 28 years of diverse experience with area of expertise as Obstetrics/gynecology. She is a member of the group practice St Tammany Parish Hospital Service District No 1 and her current practice location is 421 S 28th Ave Ste 200, Hattiesburg, Mississippi. You can reach out to her office (for appointments etc.) via phone at (601) 268-5640.

Dr Christina Lynn Goodridge is licensed to practice in Mississippi (license number 16873) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033195375.

Contact Information

Dr Christina Lynn Goodridge, MD
421 S 28th Ave Ste 200,
Hattiesburg, MS 39401-7208
(601) 268-5640
Not Available



Physician's Profile

Full NameDr Christina Lynn Goodridge
GenderFemale
SpecialityObstetrics/gynecology
Experience28 Years
Location421 S 28th Ave Ste 200, Hattiesburg, Mississippi
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Christina Lynn Goodridge attended and graduated from Georgetown University School Of Medicine in 1996
  NPI Data:
  • NPI Number: 1033195375
  • Provider Enumeration Date: 12/19/2005
  • Last Update Date: 01/29/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 7810916186
  • Enrollment ID: I20051116000061

Medical Identifiers

Medical identifiers for Dr Christina Lynn Goodridge such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033195375NPI-NPPES
1484261MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 16873 (Mississippi)Primary
207V00000XObstetrics & Gynecology 023094 (Louisiana)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
St Tammany Parish Hospital Service District No 10749273761138

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Christina Lynn Goodridge allows following entities to bill medicare on her behalf.
Entity NameSt Tammany Parish Hospital Service District No 1
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598798597
PECOS PAC ID: 0749273761
Enrollment ID: O20051102000003

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more Medical News

› Verified 9 days ago

Entity NameNorth Oaks Obstetrics & Gynecology
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659313245
PECOS PAC ID: 7618976440
Enrollment ID: O20061205000501

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more Medical News

› Verified 9 days ago

Entity NameDhp Of Louisiana Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013303056
PECOS PAC ID: 1658683701
Enrollment ID: O20150702001875

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more Medical News

› Verified 9 days ago

Entity NameObhg Louisiana Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639567316
PECOS PAC ID: 9234443250
Enrollment ID: O20150805006718

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Christina Lynn Goodridge is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Christina Lynn Goodridge, MD
4224 Houma Blvd, Suite 140,
Metairie, LA 70006-2933

Ph: (504) 888-2080
Dr Christina Lynn Goodridge, MD
421 S 28th Ave Ste 200,
Hattiesburg, MS 39401-7208

Ph: (601) 268-5640

News Archive

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

Scientists identify more than 100 new cases of alkaptonuria

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously thought.

Read more News

› Verified 9 days ago


Obstetrics & Gynecology Doctors in Hattiesburg, MS

Jeffrey L Hudson, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401
Phone: 601-268-5640    Fax: 601-261-3507
Dr. William L Pace, M.D.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 6524 U S Highway 98, Hattiesburg, MS 39402
Phone: 601-268-9393    Fax: 601-268-9559
Kelly R O'neal, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401
Phone: 601-268-5640    Fax: 601-261-3507
Dr. Eldred J Wiser, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 6524 U S Highway 98, Hattiesburg, MS 39402
Phone: 601-268-9393    Fax: 601-268-9559
Lauren Ayres Bethea, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 421 S 28th Ave, Suite 200, Hattiesburg, MS 39401
Phone: 601-268-5640    Fax: 601-261-3507
Dr. Eugene Linwood Shannon, M.D.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 62 Old Airport Rd, Hattiesburg, MS 39401
Phone: 601-544-4550    Fax: 601-582-3373

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.